PHARMA 4.0

Sales & Marketing

HCP marketing’s Pharma 4.0 moment: Leveraging AI for real-ti...

With healthcare marketing becoming more digital than ever, artificial intelligence (AI) for marketers has ceased to be merely a buzzword.

Partner Content

Partner Content

Latest challenges in pharmaceutical trade

Parallel Trade Conference

News

JPM: AbbVie pays $650m upfront for RemeGen cancer drug

AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Editor's Picks